Market revenue in 2023 | USD 156.1 million |
Market revenue in 2030 | USD 269.1 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.3% in 2023. Horizon Databook has segmented the Japan implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
The rising geriatric population in Japan and the increased risk of CVDs have created a significant market opportunity for ICDs. In September 2022, Japan’s population declined by 820,000, while the number of seniors aged 65 years and older increased by 60,000, reaching a record total of 36.27 million individuals.
This surge in the senior population marked a 0.03% increase from the previous (2021) year, representing the highest growth rate recorded thus far. Moreover, the prevalence of CVDs is expected to rise with the growing aging population.
This is increasing the demand for advanced cardiac care and treatment options. ICDs, implantable devices capable of detecting and correcting life-threatening irregular heart rhythms, have become vital in managing CVD among older people.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into Japan implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account